HEMOSPEC
Advanced spectroscopic hemogram for personalized care against live threatening infections using an integrated chip-assisted bio-photonic system
| Coordinatore | INSTITUT FUER PHOTONISCHE TECHNOLOGIEN E.V.
Organization address
address: Albert Einstein strasse 9 contact info |
| Nazionalità Coordinatore | Germany [DE] |
| Totale costo | 5˙069˙233 € |
| EC contributo | 3˙777˙000 € |
| Programma | FP7-ICT
Specific Programme "Cooperation": Information and communication technologies |
| Code Call | FP7-ICT-2013-10 |
| Funding Scheme | CP |
| Anno di inizio | 2013 |
| Periodo (anno-mese-giorno) | 2013-11-01 - 2017-10-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
INSTITUT FUER PHOTONISCHE TECHNOLOGIEN E.V.
Organization address
address: Albert Einstein strasse 9 contact info |
DE (JENA) | coordinator | 0.00 |
| 2 |
Nome Ente NON disponibile
Organization address
city: Jena contact info |
DE (Jena) | participant | 0.00 |
| 3 |
BMD SOFTWARE LDA
Organization address
address: TRAVESSA DO EIRADO contact info |
PT (ARCOZELO VILA NOVA DE GAIA) | participant | 0.00 |
| 4 |
CONSIGLIO NAZIONALE DELLE RICERCHE
Organization address
address: PIAZZALE ALDO MORO contact info |
IT (ROMA) | participant | 0.00 |
| 5 |
DATAMED SRL
Organization address
address: VIA PAPA GIOVANNI XXIII contact info |
IT (RODANO (MI)) | participant | 0.00 |
| 6 |
HORIBA JOBIN YVON S.A.S.
Organization address
address: Rue du Canal 16-18 contact info |
FR (LONGJUMEAU) | participant | 0.00 |
| 7 |
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS
Organization address
address: CHRISTOU LADA contact info |
EL (ATHENS) | participant | 0.00 |
| 8 |
VIROGATES AS
Organization address
address: VEDERSGADE contact info |
DK (KOBENHAVN K) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
Life threatening infectious diseases and sepsis are worldwide problems with high mortalities. In order to select optimal treatments for the highly heterogeneous group of sepsis patients and to reduce costs, novel multiplexed tools that better characterize the patient and its specific immune response are highly desired.nIn the novel project 'HemoSpec' a multidisciplinary team develops - driven by the demands of the two clinical partners - a highly innovative technological platform for early, fast and reliable medical diagnosis of infectious diseases using only minimal amounts of patient's blood. HemoSpec combines in one device three key enabling technologies: automated microfluidic sample handling with integrated holographic blood count, simultaneous multiplex fluorescence biomarker sensing and detailed Raman spectroscopic leukocyte characterization. In each of the technologies experts in the consortium can build on previous knowledge and will improve system characteristics for higher performance and functionality. Strong focus will be on the miniaturization, optimization as well as on the integration of the individual parts. One common user interface, common data storage and analysis software will make the dense information from HemoSpec available to the clinical enduser in a single working step. The integrated multiplex analysis of HemoSpec will be validated in two clinics in two countries specialized on hospital-acquired and community-acquired sepsis, respectively.nStrong industrial participation (four companies from four different countries) spanning the portfolio from biomarker supply to spectrometer companies up to software integrators assures ultimate exploitation of the innovative developments and the final device on the market leading to enhanced European market leadership in the field of medical diagnosis. Ultimately, this can help to administer the right therapy to the right patient at the right time reducing the costs in the health care sector.